Mannkind

MNKDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.322 B

$4.11 +5.66%

Close of 7 Aug 2026

Revenue

$349.0M

#2077 by revenue

Earnings

$5.86M

#2168 by earnings

Shares outstanding

321,540,637

Latest filing cover page

P/E ratio

225.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#146SchrodingerSDGR$1.36B
#147MoonLake ImmunotherapeuticsMLTX$1.34B
#148MannkindMNKD$1.32B
#149Seaport TherapeuticsSPTX$1.26B
#150Eton PharmaceuticalsETON$1.22B

Where these numbers come from

Share counts and financials for Mannkind are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.